The safety of blinatumomab in pediatric patients with acute lymphoblastic leukemia: A systematic review and meta-analysis

BackgroundBlinatumomab is a bispecific CD19-directed CD3 T-cell engager that has proven efficacy in children with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL). Despite its efficacy, it has also been associated with the development of potentially serious adverse events such as the...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Maria Maddalena Marrapodi (Author), Annamaria Mascolo (Author), Gabriella di Mauro (Author), Gianluca Mondillo (Author), Elvira Pota (Author), Francesca Rossi (Author)
Formato: Libro
Publicado: Frontiers Media S.A., 2022-07-01T00:00:00Z.
Subjects:
Acceso en liña:Connect to this object online.
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Dispoñible